Sionna therapeutics announces presentation of preclinical data that demonstrate proprietary dual combination therapies enable full cftr correction in cfhbe model

Data featured in oral presentation and poster session at 48 th european cystic fibrosis conference

SION Ratings Summary

SION Quant Ranking